The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

XOMA Corp

Nasdaq: XOMA(*D)
Last

(U.S.) $0.48

Today's change0.00 0.00%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

XOMA Corp

Nasdaq: XOMA(*D)
Last

(U.S.) $0.48

Today's change0.00 0.00%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

XOMA Corp closed at (U.S.)$0.48.

Over the last five days, shares have lost 5.55% and are down 63.78% for the last year to date. This security has underperformed the S&P 500 by 52.43% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $0.48
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-63.78%
  • Volume0
  • Average volume (10-day)1,366,733
  • Average volume (1-month)933,229
  • Average volume (3-month)1,026,014
  • 52-week range(U.S.) $0.44 to (U.S.) $2.03
  • Beta2.86
  • Trailing P/E36.08×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.01
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.46%

Based on its net profit margin of 2.46%, XOMA Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue04482
Total other revenue--------
Total revenue04482
Gross profit--------
Total cost of revenue--------
Total operating expense18181926
Selling / general / administrative5456
Research & development14141418
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0013
Other operating expenses, total--------
Operating income-18-1429-24
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-8250
Income after tax-15-8250
Income tax, total--------
Net income-15-8250
Total adjustments to net income--------
Net income before extra. items-15-8250
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-15-8250
Inc. avail. to common incl. extra. items-15-8250
Diluted net income-15-8250
Dilution adjustment--------
Diluted weighted average shares120120119119
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.070.210.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.13-0.070.220.02